CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...